These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A tale of three PKCs: epsilon emerges as a driver of pre-neoplastic phenotypes. Knudsen KE Cell Cycle; 2011 Feb; 10(3):379. PubMed ID: 21270526 [No Abstract] [Full Text] [Related]
3. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice. Blando JM; Carbajal S; Abel E; Beltran L; Conti C; Fischer S; DiGiovanni J Neoplasia; 2011 Mar; 13(3):254-65. PubMed ID: 21390188 [TBL] [Abstract][Full Text] [Related]
4. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision. Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724 [TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon). Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280 [TBL] [Abstract][Full Text] [Related]
7. PKCε paves the way for prostate cancer. Basu A Cell Cycle; 2011 Feb; 10(3):378. PubMed ID: 21270525 [No Abstract] [Full Text] [Related]
8. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403 [TBL] [Abstract][Full Text] [Related]
9. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia. Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1. Powell CT; Yin L Int J Cancer; 2006 Mar; 118(6):1572-6. PubMed ID: 16184549 [TBL] [Abstract][Full Text] [Related]
11. Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer. Hafeez BB; Meske L; Singh A; Singh A; Zhong W; Powers P; John M; Griep AE; Verma AK Oncotarget; 2016 May; 7(22):33069-80. PubMed ID: 27102301 [TBL] [Abstract][Full Text] [Related]
12. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway. Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643 [TBL] [Abstract][Full Text] [Related]
13. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways. Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209 [TBL] [Abstract][Full Text] [Related]
14. MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors. Clegg NJ; Couto SS; Wongvipat J; Hieronymus H; Carver BS; Taylor BS; Ellwood-Yen K; Gerald WL; Sander C; Sawyers CL PLoS One; 2011 Mar; 6(3):e17449. PubMed ID: 21394210 [TBL] [Abstract][Full Text] [Related]
15. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P. Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes. Li L; Sampat K; Hu N; Zakari J; Yuspa SH J Biol Chem; 2006 Feb; 281(6):3237-43. PubMed ID: 16338928 [TBL] [Abstract][Full Text] [Related]
17. Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer. Wang Y; Kasper S; Yuan J; Jin RJ; Zhang J; Ishii K; Wills ML; Hayward SW; Matusik RJ Lab Invest; 2006 Oct; 86(10):1074-88. PubMed ID: 16894353 [TBL] [Abstract][Full Text] [Related]
18. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799 [TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes. Rybin VO; Guo J; Gertsberg Z; Elouardighi H; Steinberg SF J Biol Chem; 2007 Aug; 282(32):23631-8. PubMed ID: 17569658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]